Capital Advisory Group Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-580	Closed	-$52K	–	200
2022 Q2	$52K	Hold	580	–	–	0.03%	158
2022 Q1	$52K	Buy	+580	New	+$53.6K	0.02%	238
2021 Q4	–	Sell	-580	Closed	-$73K	–	520
2021 Q3	$73K	Hold	580	–	–	0.03%	249
2021 Q2	$79K	Hold	580	–	–	0.03%	243
2021 Q1	$79K	Sell	580 -50	-8%	-$7.49K	0.03%	222
2020 Q4	$89K	Hold	630	–	–	0.04%	217
2020 Q3	$70K	Hold	630	–	–	0.04%	192
2020 Q2	$71K	Buy	630 +50	+9%	+$4.92K	0.04%	186
2020 Q1	$45K	Sell	580 -25	-4%	-$2.21K	0.06%	115
2019 Q4	$58K	Hold	605	–	–	0.03%	126
2019 Q3	$47K	Hold	605	–	–	0.03%	151
2019 Q2	$53K	Hold	605	–	–	0.04%	150
2019 Q1	$56K	Sell	605 -105	-15%	-$8.93K	0.04%	141
2018 Q4	$52K	Hold	710	–	–	0.04%	135
2018 Q3	$68K	Hold	710	–	–	0.05%	123
2018 Q2	$68K	Hold	710	–	–	0.05%	118
2018 Q1	$62K	Buy	+710	New	+$64.8K	0.05%	126

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Capital Advisory Group Advisory Services's XBI Position: Q3 2022 in Review

Capital Advisory Group Advisory Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 580 shares — an estimated $52K sold.

Capital Advisory Group Advisory Services first reported a position in XBI in Q1 2018 and held it in 17 quarters. The position peaked at $89K in Q4 2020. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Capital Advisory Group Advisory Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 580 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $52K.
Capital Advisory Group Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 17 quarters.
Capital Advisory Group Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $89K in Q4 2020.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q3 2022, filed 7 Nov 2022.